200 related articles for article (PubMed ID: 24140226)
1. A comparison of cognitive-behavioral therapy, antidepressants, their combination and standard treatment for Chinese patients with moderate-severe major depressive disorders.
Zu S; Xiang YT; Liu J; Zhang L; Wang G; Ma X; Kilbourne AM; Ungvari GS; Chiu HF; Lai KY; Wong SY; Yu DS; Li ZJ
J Affect Disord; 2014 Jan; 152-154():262-7. PubMed ID: 24140226
[TBL] [Abstract][Full Text] [Related]
2. Prevention of Recurrence After Recovery From a Major Depressive Episode With Antidepressant Medication Alone or in Combination With Cognitive Behavioral Therapy: Phase 2 of a 2-Phase Randomized Clinical Trial.
DeRubeis RJ; Zajecka J; Shelton RC; Amsterdam JD; Fawcett J; Xu C; Young PR; Gallop R; Hollon SD
JAMA Psychiatry; 2020 Mar; 77(3):237-245. PubMed ID: 31799993
[TBL] [Abstract][Full Text] [Related]
3. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
[TBL] [Abstract][Full Text] [Related]
4. Benefits of Sequentially Adding Cognitive-Behavioral Therapy or Antidepressant Medication for Adults With Nonremitting Depression.
Dunlop BW; LoParo D; Kinkead B; Mletzko-Crowe T; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
Am J Psychiatry; 2019 Apr; 176(4):275-286. PubMed ID: 30764648
[TBL] [Abstract][Full Text] [Related]
5. Web-Based Cognitive Behavioral Therapy Blended With Face-to-Face Sessions for Major Depression: Randomized Controlled Trial.
Nakao S; Nakagawa A; Oguchi Y; Mitsuda D; Kato N; Nakagawa Y; Tamura N; Kudo Y; Abe T; Hiyama M; Iwashita S; Ono Y; Mimura M
J Med Internet Res; 2018 Sep; 20(9):e10743. PubMed ID: 30249583
[TBL] [Abstract][Full Text] [Related]
6. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial.
Hollon SD; DeRubeis RJ; Fawcett J; Amsterdam JD; Shelton RC; Zajecka J; Young PR; Gallop R
JAMA Psychiatry; 2014 Oct; 71(10):1157-64. PubMed ID: 25142196
[TBL] [Abstract][Full Text] [Related]
7. Culturally Adapted Cognitive-Behavioral Therapy for Chinese Americans With Depression: A Randomized Controlled Trial.
Hwang WC; Myers HF; Chiu E; Mak E; Butner JE; Fujimoto K; Wood JJ; Miranda J
Psychiatr Serv; 2015 Oct; 66(10):1035-42. PubMed ID: 26129996
[TBL] [Abstract][Full Text] [Related]
8. Psychometric properties of the Chinese versions of the Quick Inventory of Depressive Symptomatology - Clinician Rating (C-QIDS-C) and Self-Report (C-QIDS-SR).
Liu J; Xiang YT; Wang G; Zhu XZ; Ungvari GS; Kilbourne AM; Lai KY; Zhong BL; Zhang L; Zhang Q; Zou YC; Xiao L; Zhao Q; Li Y; Wu J; Zhang GF; Chiu HF
J Affect Disord; 2013 May; 147(1-3):421-4. PubMed ID: 22995944
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.
Segal ZV; Bieling P; Young T; MacQueen G; Cooke R; Martin L; Bloch R; Levitan RD
Arch Gen Psychiatry; 2010 Dec; 67(12):1256-64. PubMed ID: 21135325
[TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness and cost-effectiveness of cognitive behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: the CoBalT randomised controlled trial.
Wiles N; Thomas L; Abel A; Barnes M; Carroll F; Ridgway N; Sherlock S; Turner N; Button K; Odondi L; Metcalfe C; Owen-Smith A; Campbell J; Garland A; Hollinghurst S; Jerrom B; Kessler D; Kuyken W; Morrison J; Turner K; Williams C; Peters T; Lewis G
Health Technol Assess; 2014 May; 18(31):1-167, vii-viii. PubMed ID: 24824481
[TBL] [Abstract][Full Text] [Related]
11. PsychotherapyPlus: augmentation of cognitive behavioral therapy (CBT) with prefrontal transcranial direct current stimulation (tDCS) in major depressive disorder-study design and methodology of a multicenter double-blind randomized placebo-controlled trial.
Bajbouj M; Aust S; Spies J; Herrera-Melendez AL; Mayer SV; Peters M; Plewnia C; Fallgatter AJ; Frase L; Normann C; Behler N; Wulf L; Brakemeier EL; Padberg F
Eur Arch Psychiatry Clin Neurosci; 2018 Dec; 268(8):797-808. PubMed ID: 29214483
[TBL] [Abstract][Full Text] [Related]
12. Novel Augmentation Strategies in Major Depression.
Martiny K
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
[TBL] [Abstract][Full Text] [Related]
13. Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study.
Dunlop BW; Kelley ME; Aponte-Rivera V; Mletzko-Crowe T; Kinkead B; Ritchie JC; Nemeroff CB; Craighead WE; Mayberg HS;
Am J Psychiatry; 2017 Jun; 174(6):546-556. PubMed ID: 28335624
[TBL] [Abstract][Full Text] [Related]
14. A comparison of cognitive-behavioral therapy, sertraline, and their combination for adolescent depression.
Melvin GA; Tonge BJ; King NJ; Heyne D; Gordon MS; Klimkeit E
J Am Acad Child Adolesc Psychiatry; 2006 Oct; 45(10):1151-1161. PubMed ID: 17003660
[TBL] [Abstract][Full Text] [Related]
15. Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder.
Dunlop BW; Cole SP; Nemeroff CB; Mayberg HS; Craighead WE
J Affect Disord; 2018 Mar; 229():111-119. PubMed ID: 29306690
[TBL] [Abstract][Full Text] [Related]
16. Interventions to improve return to work in depressed people.
Nieuwenhuijsen K; Verbeek JH; Neumeyer-Gromen A; Verhoeven AC; Bültmann U; Faber B
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD006237. PubMed ID: 33052607
[TBL] [Abstract][Full Text] [Related]
17. The Appalachia Mind Health Initiative (AMHI): a pragmatic randomized clinical trial of adjunctive internet-based cognitive behavior therapy for treating major depressive disorder among primary care patients.
Bossarte RM; Kessler RC; Nierenberg AA; Chattopadhyay A; Cuijpers P; Enrique A; Foxworth PM; Gildea SM; Belnap BH; Haut MW; Law KB; Lewis WD; Liu H; Luedtke AR; Pigeon WR; Rhodes LA; Richards D; Rollman BL; Sampson NA; Stokes CM; Torous J; Webb TD; Zubizarreta JR
Trials; 2022 Jun; 23(1):520. PubMed ID: 35725644
[TBL] [Abstract][Full Text] [Related]
18. Cost and Outcome of BehaviouRal Activation (COBRA): a randomised controlled trial of behavioural activation versus cognitive-behavioural therapy for depression.
Richards DA; Rhodes S; Ekers D; McMillan D; Taylor RS; Byford S; Barrett B; Finning K; Ganguli P; Warren F; Farrand P; Gilbody S; Kuyken W; O'Mahen H; Watkins E; Wright K; Reed N; Fletcher E; Hollon SD; Moore L; Backhouse A; Farrow C; Garry J; Kemp D; Plummer F; Warner F; Woodhouse R
Health Technol Assess; 2017 Aug; 21(46):1-366. PubMed ID: 28857042
[TBL] [Abstract][Full Text] [Related]
19. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.
Amick HR; Gartlehner G; Gaynes BN; Forneris C; Asher GN; Morgan LC; Coker-Schwimmer E; Boland E; Lux LJ; Gaylord S; Bann C; Pierl CB; Lohr KN
BMJ; 2015 Dec; 351():h6019. PubMed ID: 26645251
[TBL] [Abstract][Full Text] [Related]
20. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
Davis AK; Barrett FS; May DG; Cosimano MP; Sepeda ND; Johnson MW; Finan PH; Griffiths RR
JAMA Psychiatry; 2021 May; 78(5):481-489. PubMed ID: 33146667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
